Galway Biomedical develops and manufactures medical devices.
Ovagen is a biotechnology company specializing in the large-scale production of germ-free chicken eggs and birds, primarily for the pharmaceutical industry. The company's innovative process utilizes a transgenic chicken platform to produce recombinant proteins to Good Manufacturing Practice (GMP) standards. This technology provides pharmaceutical companies with a biosecure and flexible biomanufacturing solution for developing vaccines and therapeutic proteins. In addition to its core offerings, Ovagen also provides Contract Research Services and has expertise in specific poultry and rodent research technologies, as well as in SPF poultry and rodent housing and husbandry.
Peroptyx specializes in providing location-based machine learning training data and model evaluation solutions for technology brands worldwide. The company's platform integrates personalized authentication, onboarding, and performance analytics to support a community of expert data analysts who ensure high-quality training data. By focusing on data security, geo-location, and identity innovations, Peroptyx aims to reduce bias and errors in machine learning training data. This enables organizations to develop and deploy more accurate and locally relevant AI models across various applications, including maps, search, music, voice, and generative artificial intelligence services.
CitySwift is a technology company based in Galway, Ireland, specializing in data-driven scheduling and planning for urban bus networks. Founded in 2016 by Alan Farrelly and Brian O'Rourke, the company utilizes artificial intelligence and machine learning to analyze historical patterns related to weather, traffic, and events. This analysis allows CitySwift to predict journey times and passenger demand, enabling bus operators to create optimized timetables that enhance operational efficiency. By considering various external factors, CitySwift's platform aims to improve on-time performance and passenger satisfaction while reducing waste in public transport services. The company provides tools that help bus operators better match vehicle availability with commuter needs, ultimately promoting quality public transport solutions at an affordable cost.
FeelTect is a medical device company based in Galway, Ireland, founded in 2019. The company specializes in developing and marketing a connected-health technology known as Tight Alright, which is designed to measure and monitor sub-bandage pressure during compression therapy for venous leg ulcers (VLUs). This technology addresses a critical challenge in VLU treatment, as improper pressure application can lead to ineffective or dangerous outcomes. By providing live readings and recorded data, FeelTect's device allows both patients and healthcare providers to ensure that compression therapy is applied safely and effectively, ultimately facilitating optimal, individualized treatment regimens. The innovation not only enhances patient care but also aims to reduce the economic burden associated with VLU management.
Amara Therapeutics is focused on enhancing pelvic health for both women and men through a digital therapeutic platform. The company employs evidence-based medicine and behavioral interventions to create safe, convenient, and non-invasive care pathways. Its technology enables the tracking of patient-specific conditions and treatment strategies while offering pelvic floor muscle training and expert-led education on pelvic and bladder health. By connecting healthcare providers, patients, and peers, Amara Therapeutics aims to improve the overall care experience for pelvic health patients, ensuring they have access to affordable and effective treatment options.
Bluedrop Medical Limited specializes in developing, manufacturing, and commercializing an Internet of Things-enabled device designed for the early detection of diabetic foot ulcers. Founded in 2014 and based in Galway, Ireland, the company offers a home-based system that conducts daily scans of patients' feet. This data is then transmitted to the cloud for analysis using advanced algorithms capable of identifying abnormalities. By detecting skin damage early, the device aims to significantly reduce the risk of amputation, which is a critical concern as up to 25% of individuals with diabetes may develop foot ulcers, often due to peripheral neuropathy. The innovative technology not only enhances patient care but also has the potential to lower healthcare costs associated with severe complications arising from untreated foot ulcers.
ByoWave has developed the Proteus Controller, a modular, accessible video game controller for disabled and non-disabled gamers.
Ovagen is a biotechnology company specializing in the large-scale production of germ-free chicken eggs and birds, primarily for the pharmaceutical industry. The company's innovative process utilizes a transgenic chicken platform to produce recombinant proteins to Good Manufacturing Practice (GMP) standards. This technology provides pharmaceutical companies with a biosecure and flexible biomanufacturing solution for developing vaccines and therapeutic proteins. In addition to its core offerings, Ovagen also provides Contract Research Services and has expertise in specific poultry and rodent research technologies, as well as in SPF poultry and rodent housing and husbandry.
CitySwift is a technology company based in Galway, Ireland, specializing in data-driven scheduling and planning for urban bus networks. Founded in 2016 by Alan Farrelly and Brian O'Rourke, the company utilizes artificial intelligence and machine learning to analyze historical patterns related to weather, traffic, and events. This analysis allows CitySwift to predict journey times and passenger demand, enabling bus operators to create optimized timetables that enhance operational efficiency. By considering various external factors, CitySwift's platform aims to improve on-time performance and passenger satisfaction while reducing waste in public transport services. The company provides tools that help bus operators better match vehicle availability with commuter needs, ultimately promoting quality public transport solutions at an affordable cost.
Founded in 2014 by Eoin Bambury and Moshe Zilversmit, Signum Surgical is a medtech platform striving to develop technology that could cure perianal fistula. Bambury and Zilversmit, who met on the BioInnovate Ireland programme at NUI Galway, recognised a lack of innovation surrounding the treatment of perianal fistulas (small tunnels that develop between the end of the bowel and the skin near the anus). The device developed by Signum Surgical is implanted post-surgery to prevent reinfection and to allow a faster healing process.
3D Issue is a publishing platform specializing in the design and deployment of interactive digital publications. The platform facilitates the creation of mobile-responsive content that is adaptable across various devices, ensuring an engaging reader experience. It features an integrated loader to expedite the conversion and publication process, along with analytics services that allow users to monitor reader engagement and refine their content accordingly. Additionally, 3D Issue provides built-in sharing capabilities, enabling users to efficiently distribute their multi-screen digital publications across multiple digital channels.
Hooke Bio Ltd., established in 2014 and located in Shannon, Ireland, specializes in developing microfluidic-based technologies for drug screening and related applications. The company has created a fully integrated high throughput screening system that focuses on 3D microtissues, including spheroids, organoids, and mini-organs. Its patented Mera technology generates biological data from these microtissues, aiming to minimize the use of animal models in preclinical studies and expedite drug development processes. Hooke Bio’s innovations facilitate the creation of more accurate disease models for testing new drugs and enable the testing of existing therapies using patient-specific disease samples, ultimately enhancing the ability of medical professionals to treat patients effectively.
Versono Medical is an early stage Irish MedTech company located in Galway, a global centre for excellence in medical technologies. The company collaborates with clinicians and research institutions across the world.
FeelTect is a medical device company based in Galway, Ireland, founded in 2019. The company specializes in developing and marketing a connected-health technology known as Tight Alright, which is designed to measure and monitor sub-bandage pressure during compression therapy for venous leg ulcers (VLUs). This technology addresses a critical challenge in VLU treatment, as improper pressure application can lead to ineffective or dangerous outcomes. By providing live readings and recorded data, FeelTect's device allows both patients and healthcare providers to ensure that compression therapy is applied safely and effectively, ultimately facilitating optimal, individualized treatment regimens. The innovation not only enhances patient care but also aims to reduce the economic burden associated with VLU management.
Bluedrop Medical Limited specializes in developing, manufacturing, and commercializing an Internet of Things-enabled device designed for the early detection of diabetic foot ulcers. Founded in 2014 and based in Galway, Ireland, the company offers a home-based system that conducts daily scans of patients' feet. This data is then transmitted to the cloud for analysis using advanced algorithms capable of identifying abnormalities. By detecting skin damage early, the device aims to significantly reduce the risk of amputation, which is a critical concern as up to 25% of individuals with diabetes may develop foot ulcers, often due to peripheral neuropathy. The innovative technology not only enhances patient care but also has the potential to lower healthcare costs associated with severe complications arising from untreated foot ulcers.
Tympany is a platform for performing minimally invasive ear surgeries, reducing unnecessary mastoidectomys and improving outcomes.
Content Llama Limited operates a platform that connects brands with online retailers in sectors such as sports, outdoor fashion, and pharmacy. Founded in 2019 and based in Donegal, Ireland, the company specializes in automating the collection, configuration, and delivery of product content for eCommerce. Utilizing advanced Content Configuration Technology, Content Llama provides tailored product descriptions and images directly to retailers, ensuring that the content meets their specific requirements and scales effectively. The platform acts as a Digital Content Gateway, sourcing, organizing, and transforming brand content into a unified format that feeds retailers' internal systems, including Product Information Management (PIM), Digital Asset Management (DAM), and eCommerce platforms. By delivering fast, high-quality, and accurate product content, Content Llama enhances online merchandising and helps retailers succeed in a competitive digital landscape.
Locker is a digital sports content platform that transforms how fans engage with sports media through personalization. Utilizing advanced machine-learning techniques and content aggregation, Locker allows users to curate a personalized experience by selecting from numerous media brands and topics. The app indexes over 1,500 sports publications and analyzes more than 5,000 articles daily, ensuring users receive tailored news feeds and real-time updates relevant to their interests. Currently available in the UK and Ireland, Locker primarily focuses on written content, with plans to expand into video and audio formats. This innovative approach enables fans to stay informed and connected with their favorite teams and topics through a single, user-friendly application.
Palliare focuses on advancing smoke insufflation and evacuation technologies for various surgical procedures, including robotic, laparoscopic, endoluminal, and colorectal surgeries. The company offers products such as the EVA15 insufflator and a comprehensive smoke evacuation system. Palliare aims to enhance surgical workflows by integrating its technologies with existing systems, thereby safeguarding operating room staff from the hazards associated with surgical smoke and aerosolized viruses. Their mission is to become a leader in advanced insufflation technology, catering to the needs of minimally invasive surgical practices.
Peroptyx specializes in providing location-based machine learning training data and model evaluation solutions for technology brands worldwide. The company's platform integrates personalized authentication, onboarding, and performance analytics to support a community of expert data analysts who ensure high-quality training data. By focusing on data security, geo-location, and identity innovations, Peroptyx aims to reduce bias and errors in machine learning training data. This enables organizations to develop and deploy more accurate and locally relevant AI models across various applications, including maps, search, music, voice, and generative artificial intelligence services.
Atlantic Therapeutics Limited is a medical technology company specializing in the development and distribution of devices for pelvic floor muscle strengthening and nerve stimulation. The company offers Innovotherapy, a device that addresses these needs, as well as INNOVO, a wearable solution designed specifically for treating stress urinary incontinence, a common cause of bladder weakness. Established in 2013, Atlantic Therapeutics is headquartered in Galway, Ireland, with additional offices in London, Paris, and Salem, Germany. Its products are distributed across Ireland, the United Kingdom, France, Germany, and the Middle East. Atlantic Therapeutics operates as a subsidiary of Bio-Medical Research Limited.
InVera Medical is a developer of innovative medical devices aimed at treating varicose veins and venous ulcers. The company focuses on creating less invasive, pain-free treatment options that leverage the body's natural biological responses. Their proprietary technology provides a minimally invasive endovenous treatment that enhances patient safety and efficacy, addressing a significant gap in the market where only a small fraction of the 120 million individuals suffering from venous disease in the US and EU receive adequate care. With an estimated 3 million patients with venous ulcers currently underserved and reliant on ineffective compression bandaging, InVera Medical offers a solution that not only improves treatment outcomes but also seeks to reduce the substantial annual costs incurred by insurers. Their approach is positioned to disrupt conventional treatment practices and expand the indications for superficial venous ablation, ultimately enhancing access to effective care for a broader range of patients.
Fincovi specializes in providing cloud-based software solutions for renewable energy companies, focusing on enhancing financial management and compliance. Its platform aims to streamline back- and middle-office operations, reducing costs while improving the consistency and reliability of information shared among stakeholders. By leveraging advanced technology, Fincovi enables developers and fund managers to effectively build, originate, and fundraise for new renewable energy projects. Through its open and connected ecosystem, the company seeks to maximize the value of investment portfolios in the renewable sector.
Cerebreon Technologies Ltd., founded in 2016 and headquartered in Portnoo, Ireland, specializes in developing software solutions for the insolvency market. The company focuses on advanced data analytics, business management systems, and process automation. Its software is designed to enhance debt recovery processes by utilizing machine learning and smart analytics to predict outcomes and improve operational efficiency. By identifying potential customer defaults early, Cerebreon's solutions help creditors and insolvency practitioners take preventative action, thereby reducing costs and ensuring compliance. The company aims to make high-end analytics accessible to businesses of all sizes and sectors, providing tailored software solutions and expert consultancy services.
A community project bridging the disconnect between remote work and local impact in rural area.
AtriAN Medical is an Irish medical device company based in Galway, specializing in innovative treatments for atrial fibrillation. The company has commercialized technology developed at the Mayo Clinic, focusing on a unique approach that utilizes micro Pulsed Electric Fields (mPEF) to selectively ablate hyperactive tissues while preserving surrounding myocardial tissue. AtriAN's device employs a catheter to deliver short pulses of electrical energy to the clusters of neuronal cells responsible for the condition. This method allows for effective treatment without causing damage to the heart muscle, offering physicians a new option in managing atrial fibrillation and improving patient outcomes.
Bluedrop Medical Limited specializes in developing, manufacturing, and commercializing an Internet of Things-enabled device designed for the early detection of diabetic foot ulcers. Founded in 2014 and based in Galway, Ireland, the company offers a home-based system that conducts daily scans of patients' feet. This data is then transmitted to the cloud for analysis using advanced algorithms capable of identifying abnormalities. By detecting skin damage early, the device aims to significantly reduce the risk of amputation, which is a critical concern as up to 25% of individuals with diabetes may develop foot ulcers, often due to peripheral neuropathy. The innovative technology not only enhances patient care but also has the potential to lower healthcare costs associated with severe complications arising from untreated foot ulcers.
Hooke Bio Ltd., established in 2014 and located in Shannon, Ireland, specializes in developing microfluidic-based technologies for drug screening and related applications. The company has created a fully integrated high throughput screening system that focuses on 3D microtissues, including spheroids, organoids, and mini-organs. Its patented Mera technology generates biological data from these microtissues, aiming to minimize the use of animal models in preclinical studies and expedite drug development processes. Hooke Bio’s innovations facilitate the creation of more accurate disease models for testing new drugs and enable the testing of existing therapies using patient-specific disease samples, ultimately enhancing the ability of medical professionals to treat patients effectively.
Loci Orthopaedics Limited, based in Upper Newcastle, Ireland, specializes in developing innovative medical technologies to address significant unmet clinical needs in orthopedics. Founded in 2017, the company focuses on creating surgical implants, particularly the InDx implant, which is designed to treat arthritis in the thumb base joint. This implant uniquely mimics the natural motions of the thumb joint, offering a less invasive and easier insertion method compared to existing surgical options. Additionally, Loci Orthopaedics is known for its Osteoanchor surface architecture, which is based on evidence-based designs, enabling clinicians to effectively address challenges in orthopedic extremities.
Neurent Medical Limited is a medical device company based in Galway, Ireland, founded in 2015. The company focuses on developing innovative solutions for treating rhinitis, including both allergic and non-allergic forms. It offers a single-use, minimally invasive device designed for ENT surgeons that utilizes radio-frequency technology to provide non-surgical interventions for chronic rhinitis. The device is introduced through the nostrils into the nasal cavity under direct endoscopic visualization, where it employs a microelectrode array to deliver targeted energy. This approach interrupts the autonomic function within the mucosal structures of the nasal cavities, effectively reversing the inflammatory process. By enabling treatment in an office setting, Neurent Medical aims to eliminate the complications and costs associated with traditional surgical procedures.
Kite Medical has created an innovative device designed to detect kidney reflux in children experiencing urinary tract infections. This non-invasive diagnostic solution simplifies the detection process, eliminating the need for complex procedures and hospital visits. Kidney reflux, the most common urological disorder in childhood, affects up to three percent of young children, particularly those aged six months to five years. While the condition may resolve as children grow, undiagnosed and untreated cases can lead to serious consequences, including permanent kidney damage and kidney failure. By providing a straightforward and accessible means of diagnosis, Kite Medical aims to improve the management of this prevalent condition in pediatric patients.
Neuravi Limited, founded in 2009 and headquartered in Galway, Ireland, specializes in the design and development of innovative clot retrieval devices aimed at restoring blood flow in patients experiencing ischemic strokes caused by arterial blockages in the brain. The company's primary product, the EmboTrap revascularization device, is utilized in the treatment of acute ischemic strokes and is available in several European countries, including Belgium, Denmark, France, Germany, and Spain. Neuravi's focus on neuro-interventional therapies is backed by extensive research into the mechanisms of stroke, particularly regarding the capture and removal of clots, which enhances treatment efficacy and improves patient outcomes. The company collaborates with international researchers and clinicians to foster the development of new solutions for this critical medical challenge. As of April 2017, Neuravi operates as a subsidiary of DePuy Ireland Unlimited Company.
Embo Medical is based in National University of Ireland. Embo is developing the first true one-shot (one device per vessel) vascular embolisation device. The product is aimed at the peripheral vascular embolization market, a market where physicians perform about 180,000 procedures per year worldwide.
Good4U, established in 2004 by Bernie and her daughter Michelle, a certified dietitian and nutritionist, specializes in the production of nutritious sprouts and shoots. The company offers a unique 'Super Sprouts' mix, which combines brocco sprouts and super shoots, aimed at enhancing health and well-being. Committed to providing plant-based products, Good4U ensures that its offerings are free from additives and preservatives, catering to health-conscious consumers, including athletes seeking daily nutritional supplements. Through its focus on quality and affordability, Good4U delivers nutritious food options that promote a healthy lifestyle.
SyncroPhi Systems Ltd., based in Galway, Ireland, specializes in the development and commercialization of advanced wireless patient-monitoring systems tailored for medical practices in front-line settings, primarily within the European Union. The company offers KEWS300, a nursing software that provides healthcare professionals with accurate point-of-care information, enhancing patient care and improving workflow efficiency. SyncroPhi Systems operates under an ISO 13485:2003 certified Quality Management System, ensuring that all products are designed and manufactured in compliance with relevant regulatory standards. Founded in 2007, the company focuses on delivering real-time tracking and support for patient care, ultimately contributing to hospital research and the overall quality of healthcare delivery.
Kelsius is the supplier of automation technology for product safety and compliance to the food services and healthcare industries. Using the wireless temperature monitoring technology, digital HACCP Management system, and cloud based data hosting and processing, Kelsius systems improve product safety, ensure regulatory compliance, and optimize costs associated with these activities. Kelsius was founded 2003 and is headquartered in Donegal, Ireland
Marvao Medical Devices, Ltd. specializes in the development, manufacturing, and marketing of medical devices aimed at reducing the risk of catheter-related bloodstream infections. The company has created an implantable device specifically designed to manage the exit sites of central venous catheters, providing a natural barrier that helps protect patients requiring long-term vascular access. Through its innovative technology, Marvao Medical addresses a critical need in the healthcare sector, enhancing patient safety and outcomes.
FMC-Tech Ltd, was set up in August 2001, for the purpose of developing a new network management system, the Crystal SystemTM, for medium voltage overhead electricity networks. The development brief was to provide a complete solution to improve customer satisfaction and meet regulatory demands both present and future, by delivering network intelligence, while at the same time reducing costs.
Touch Ltd., a software company, provides integrated and unified audio visual and information technology convergence solutions. It offers 3touch ENTERPRISE, a client server based multimedia solution that stores, manages, and controls various presentation and multimedia materials, as well as allows access to and play-out that information; and 3touch Media Editor software, which helps to develop a digital signage playlist. The company also provides 3touch Room Control, a system designed to link to various legacy control solutions and interact with existing or new installs; and 3touch TV network, a video delivery and display system that plays live video either on demand or according to a preset schedule. In addition, it offers 3touch Encoding, which provides various ways to get the live stream on the network; and 3touch Video on Demand Module, a system that streams content through a set-top box, allows viewing in real time, or allows watching it through a software player. Te company’s solutions are used in various audio visual areas, such as presentation and content management and delivery, interactive whiteboard applications, room control, room booking and management system, automated video conferencing scheduling and setup, equipment and personal computer monitoring, and IPTV/ video on demand and digital signage. 3Touch Ltd. was founded in 2003 and is headquartered in Athlone, Ireland with additional offices in Cambridge, the United Kingdom.
Lightstorm Networks designs, develops, and supplies semiconductor solutions. It provides hardware and software subsystems. The company's products include Brooklyn-10 Carrier Ethernet Switch, a layer 2 switch with an integrated 20G traffic manager; Solas Software Suite, a carrier Ethernet software development platform, including APIs, drivers, and development tools; and B-10 Development Platform, a 3RU development system that demonstrates the functionality of the Brooklyn-10 and partner silicon solutions. Its products are used in multiservice provisioning platform, wireless backhaul, document library, and carrier Ethernet switch and router applications.